FindTrial
Sign In

N/A - MMP-Doxi-1

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-000748-81-FI
Enrollment
Unknown
Registered
2012-03-06
Start date
2012-04-02
Completion date
Unknown
Last updated
2013-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10062357 Term: SIRS System Organ Class: 10018065 - General disorders and administration site conditions MedDRA version: 14.1 Level: LLT Classification code 10040072 Term: Septicaemia System Organ Class: 10021881 - Infections and infestations

Interventions

Trade Name: Doximycin Product Name: Doximycin (doksisykliinihyklaatti) Pharmaceutical Form: Injection CAS Number: 24390-14-5 Other descriptive name: DOXYCYCLINE HYCLATE Pharmaceutical form of the pla

Sponsors

Johanna Hästbacka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 12 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 12

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026